Molecular networks in melanoma invasion and metastasis

Ewa Aladowicz, Leda Ferro, Giulio Cesare Vitali, Elisabetta Venditti, Lorenzo Fornasari, Luisa Lanfrancone

Research output: Contribution to journalArticle

Abstract

Metastatic melanoma accounts for approximately 80% of skin cancer-related deaths. Up to now there has been no effective treatment for stage IV melanoma patients due to the complexity and dissemination potential of this disease. Melanomas are heterogeneous tumors in which conventional therapies fail to improve overall survival. Targeted therapies are being developed, but the final outcome can be hampered by the incomplete knowledge of the process of melanoma progression. Even if the intracellular pathways are similar, the interaction of the cells with the surrounding environment should be taken into consideration. This article seeks to highlight some of the advances in the understanding of the molecular mechanisms underlying melanoma dissemination.

Original languageEnglish
Pages (from-to)713-726
Number of pages14
JournalFuture Oncology
Volume9
Issue number5
DOIs
Publication statusPublished - May 2013

Fingerprint

Melanoma
Neoplasm Metastasis
Skin Neoplasms
Cell Communication
Therapeutics
Survival
Neoplasms

Keywords

  • adhesion
  • melanoma
  • metastasis
  • migration
  • phenotype switching
  • RaLP/ShcD

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Aladowicz, E., Ferro, L., Vitali, G. C., Venditti, E., Fornasari, L., & Lanfrancone, L. (2013). Molecular networks in melanoma invasion and metastasis. Future Oncology, 9(5), 713-726. https://doi.org/10.2217/fon.13.9

Molecular networks in melanoma invasion and metastasis. / Aladowicz, Ewa; Ferro, Leda; Vitali, Giulio Cesare; Venditti, Elisabetta; Fornasari, Lorenzo; Lanfrancone, Luisa.

In: Future Oncology, Vol. 9, No. 5, 05.2013, p. 713-726.

Research output: Contribution to journalArticle

Aladowicz, E, Ferro, L, Vitali, GC, Venditti, E, Fornasari, L & Lanfrancone, L 2013, 'Molecular networks in melanoma invasion and metastasis', Future Oncology, vol. 9, no. 5, pp. 713-726. https://doi.org/10.2217/fon.13.9
Aladowicz E, Ferro L, Vitali GC, Venditti E, Fornasari L, Lanfrancone L. Molecular networks in melanoma invasion and metastasis. Future Oncology. 2013 May;9(5):713-726. https://doi.org/10.2217/fon.13.9
Aladowicz, Ewa ; Ferro, Leda ; Vitali, Giulio Cesare ; Venditti, Elisabetta ; Fornasari, Lorenzo ; Lanfrancone, Luisa. / Molecular networks in melanoma invasion and metastasis. In: Future Oncology. 2013 ; Vol. 9, No. 5. pp. 713-726.
@article{84be078585b34fb58e3f59693b3480dd,
title = "Molecular networks in melanoma invasion and metastasis",
abstract = "Metastatic melanoma accounts for approximately 80{\%} of skin cancer-related deaths. Up to now there has been no effective treatment for stage IV melanoma patients due to the complexity and dissemination potential of this disease. Melanomas are heterogeneous tumors in which conventional therapies fail to improve overall survival. Targeted therapies are being developed, but the final outcome can be hampered by the incomplete knowledge of the process of melanoma progression. Even if the intracellular pathways are similar, the interaction of the cells with the surrounding environment should be taken into consideration. This article seeks to highlight some of the advances in the understanding of the molecular mechanisms underlying melanoma dissemination.",
keywords = "adhesion, melanoma, metastasis, migration, phenotype switching, RaLP/ShcD",
author = "Ewa Aladowicz and Leda Ferro and Vitali, {Giulio Cesare} and Elisabetta Venditti and Lorenzo Fornasari and Luisa Lanfrancone",
year = "2013",
month = "5",
doi = "10.2217/fon.13.9",
language = "English",
volume = "9",
pages = "713--726",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - Molecular networks in melanoma invasion and metastasis

AU - Aladowicz, Ewa

AU - Ferro, Leda

AU - Vitali, Giulio Cesare

AU - Venditti, Elisabetta

AU - Fornasari, Lorenzo

AU - Lanfrancone, Luisa

PY - 2013/5

Y1 - 2013/5

N2 - Metastatic melanoma accounts for approximately 80% of skin cancer-related deaths. Up to now there has been no effective treatment for stage IV melanoma patients due to the complexity and dissemination potential of this disease. Melanomas are heterogeneous tumors in which conventional therapies fail to improve overall survival. Targeted therapies are being developed, but the final outcome can be hampered by the incomplete knowledge of the process of melanoma progression. Even if the intracellular pathways are similar, the interaction of the cells with the surrounding environment should be taken into consideration. This article seeks to highlight some of the advances in the understanding of the molecular mechanisms underlying melanoma dissemination.

AB - Metastatic melanoma accounts for approximately 80% of skin cancer-related deaths. Up to now there has been no effective treatment for stage IV melanoma patients due to the complexity and dissemination potential of this disease. Melanomas are heterogeneous tumors in which conventional therapies fail to improve overall survival. Targeted therapies are being developed, but the final outcome can be hampered by the incomplete knowledge of the process of melanoma progression. Even if the intracellular pathways are similar, the interaction of the cells with the surrounding environment should be taken into consideration. This article seeks to highlight some of the advances in the understanding of the molecular mechanisms underlying melanoma dissemination.

KW - adhesion

KW - melanoma

KW - metastasis

KW - migration

KW - phenotype switching

KW - RaLP/ShcD

UR - http://www.scopus.com/inward/record.url?scp=84877591701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877591701&partnerID=8YFLogxK

U2 - 10.2217/fon.13.9

DO - 10.2217/fon.13.9

M3 - Article

C2 - 23647299

AN - SCOPUS:84877591701

VL - 9

SP - 713

EP - 726

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 5

ER -